Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Aging & Longevity

The Truth About Full-Body MRIs: A $2,500 Investment in Your Health?

by Team Lumida
May 17, 2024
in Aging & Longevity, Health and Longevity, Lifestyle
Reading Time: 3 mins read
A A
0
man during magnetic resonance imaging

Photo by Charlss GonzHu on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Full-body MRI scans, costing $2,500, are gaining popularity among celebrities.
  2. These scans promise early disease detection but come with potential downsides.
  3. Investors eyeing the preventive healthcare market should watch for growth in services like Prenuvo.

What Happened?

Prenuvo, a company specializing in full-body MRI scans, is drawing attention with its preventive approach to health. Charging $2,500 for a comprehensive scan, Prenuvo aims to detect early signs of disease without using ionizing radiation or contrast dyes.

Founded in 2018 in Vancouver, Prenuvo expanded to New York City in April 2023, fueled by $70 million in series A funding. High-profile investors like 23andMe cofounder Anne Wojcicki and actress Cindy Crawford back the company. Demand is soaring, with new clinics opening across North America. The scans can detect tumors, aneurysms, and hundreds of other conditions.

Why It Matters?

Why should you care about Prenuvo’s MRI scans? The trend toward preventive healthcare is growing, driven by a desire to catch diseases early and maintain better health. Prenuvo’s success reflects this shift, suggesting significant market potential. Investors should note that this service, though costly, appeals to health-conscious individuals and those with high cancer risk in their families.

The company’s expansion indicates strong demand and potential for further growth. However, some medical experts caution against over-reliance on such scans, highlighting the psychological stress and potential for unnecessary follow-ups.

What’s Next?

What does the future hold for Prenuvo and similar preventive health services? Prenuvo aims to make its scans a routine part of health check-ups, similar to dental visits or physicals. The company plans to work with employers to offer scans as a benefit, potentially increasing accessibility.

For investors, this represents a growing niche in the healthcare market with substantial room for expansion. As the debate over the efficacy and necessity of full-body MRIs continues, Prenuvo’s focus on preventive care could shape future healthcare trends. Watch for further developments and potential collaborations that may influence the company’s market presence and profitability.

Previous Post

Why Investors Are Going Crazy for Copper: The $43 Billion Battle

Next Post

Inside Equinox’s Elite $40,000 Longevity Program: What You Need to Know

Recommended For You

AI Is Moving From “Wellness Hype” to Healthcare Infrastructure

by Team Lumida
8 hours ago
man running on road near grass field

Key takeaways Powered by lumidawealth.com AI is compressing the cost and time of diagnosis, monitoring, and clinical decision support—pushing healthcare toward earlier intervention and prevention. The biggest near-term value...

Read more

Diet Is the Biggest Longevity Lever Most People Underuse

by Team Lumida
4 days ago
poached egg with vegetables and tomatoes on blue plate

Key takeaways The NHS “Eatwell” approach emphasizes variety + proportions across 5 food groups, plus hydration, to support healthy weight and overall health. Most people (UK context) are...

Read more

Longevity Becomes the Next Mega-Market as Healthcare Shifts From Treating Disease to Extending Healthspan

by Team Lumida
5 days ago
diagram

Key takeaways Longevity is shifting healthcare from reactive treatment to proactive health optimization, expanding lifetime spending per person. Breakthroughs in metabolic drugs, early diagnostics, AI-driven prevention, and precision...

Read more

Ozempic Turns Weight Loss Into a New “Infrastructure” Market for Healthcare—and Investors

by Team Lumida
6 days ago
Ozempic Turns Weight Loss Into a New “Infrastructure” Market for Healthcare—and Investors

Key takeaways What it is: Ozempic is a once-weekly GLP-1 medicine approved for type 2 diabetes and to reduce major cardiovascular risk in certain adults with type 2...

Read more

Muscle Is the Longevity Hack

by Team Lumida
1 week ago
topless man with black background

Key takeaways Powered by lumidawealth.com Higher muscle mass is linked to lower mortality, better blood sugar control, and reduced risk of falls and frailty. Muscle acts as a metabolic...

Read more

Sleep Is the Most Underrated Longevity Investment

by Team Lumida
1 week ago
Sleep Paralysis Explained: The Science Behind Your Nightmares

Key takeaways Powered by lumidawealth.com Poor sleep is linked to higher risk of heart disease, diabetes, obesity, depression, and early mortality. Consistent sleep timing matters as much as total...

Read more

U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

by Team Lumida
2 weeks ago
U.S. Life Expectancy Hits Record High as Overdose Deaths Plunge

Key takeaways Powered by lumidawealth.com U.S. life expectancy rose to 79 years in 2024, the highest on record, up 0.6 years YoY Drug-overdose deaths fell more than 26%, the...

Read more

“Trump Accounts” Offer $1,000 for Kids—But the Fine Print Makes Them Tricky for Families

by Team Lumida
2 weeks ago
Trump Pushes for Greenland Acquisition, Exploring Business Deals and Military Presence

Key takeaways Powered by lumidawealth.com The program creates custodial IRA-style accounts for minors, with $1,000 Treasury seed money for eligible newborns (pilot window) Money grows tax-deferred, but withdrawals can...

Read more

Longevity Hacks Go Data-Driven as Preventive Health Becomes a Scalable Growth Market

by Team Lumida
2 weeks ago
man running on road near grass field

Key takeaways Powered by lumidawealth.com Longevity is shifting from wellness trends to measurable, science-backed health optimization Simple behaviors like strength training, protein intake, sleep consistency, and fasting windows show...

Read more

Preventive Health and Aging Tech Emerge as the Next Major Growth Market

by Team Lumida
2 weeks ago
black and red cherries on white bowl

Key takeaways Powered by lumidawealth.com Longevity is moving from niche wellness to a core healthcare and investment theme, powered by aging demographics and tech-driven prevention Breakthroughs in early diagnostics,...

Read more
Next Post
woman wearing black sports bra

Inside Equinox’s Elite $40,000 Longevity Program: What You Need to Know

Solar Charging Station in the Parking Lot

Xpeng Charges Into Hong Kong with New EV Models

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Funding Market Frenzy: What December Could Mean for Your Investments

Market Volatility 2025: Trump’s Wild Card Year

December 16, 2024
Amazon’s $100 Billion Bet: AI Over Retail

Amazon Shares Lag as Investors Await Clear AI Payoff Despite Heavy Spending

July 21, 2025
China’s Bold Economic Moves: What You Need to Know Now

China LNG Prices Sink to Five-Year Low as Weak Demand and Rising Inventories Weigh on Market

December 23, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018